Drug Repositioning of Mevalonate Pathway Inhibitors as Antitumor Agents for Ovarian Cancer
Oncotarget - United States
doi 10.18632/oncotarget.20046
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 8, 2017
Authors
Publisher
Impact Journals, LLC